Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Total Non-Current Liabilities: 2020-2024

Historic Total Non-Current Liabilities for Biofrontera (BFRI) over the last 5 years, with Dec 2024 value amounting to $16.4 million.

  • Biofrontera's Total Non-Current Liabilities rose 50.75% to $17.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.2 million, marking a year-over-year increase of 50.75%. This contributed to the annual value of $16.4 million for FY2024, which is 13.27% down from last year.
  • According to the latest figures from FY2024, Biofrontera's Total Non-Current Liabilities is $16.4 million, which was down 13.27% from $18.9 million recorded in FY2023.
  • Biofrontera's 5-year Total Non-Current Liabilities high stood at $29.0 million for FY2021, and its period low was $16.4 million during FY2024.
  • For the 3-year period, Biofrontera's Total Non-Current Liabilities averaged around $19.8 million, with its median value being $18.9 million (2023).
  • Per our database at Business Quant, Biofrontera's Total Non-Current Liabilities spiked by 59.07% in 2021 and then fell by 21.66% in 2023.
  • Over the past 5 years, Biofrontera's Total Non-Current Liabilities (Yearly) stood at $18.2 million in 2020, then surged by 59.07% to $29.0 million in 2021, then fell by 16.76% to $24.2 million in 2022, then dropped by 21.66% to $18.9 million in 2023, then declined by 13.27% to $16.4 million in 2024.